Wereport a rare case of bilateral primary adrenal non-Hodgkin's lymphoma with adrenal failure. A 66-year-old womandeveloped symptoms of adrenal failure. The cause of adrenal failure was suspected to be malignant lymphomabased on the high levels of serum soluble interleukin-2 receptor and LDH. Bilateral adrenalectomy was performed and pathological examination showed intravascular large B-cell lymphoma (IVL). Although complete remission was achieved, recurrence occurred three months later with brain metastases. IVL should be suspected in patients with bilateral adrenal tumors who present with rapidly progressive adrenal failure. (Internal Medicine 42: 609-614, 2003) 
Introduction
Malignant lymphoma could occur in any body organ.
However, non-Hodgkin lymphoma (NHL) arising in the endocrine system represents only 3%of extranodal malignant lymphomas, and is usually confined to the thyroid gland (1) . Moreover primary adrenal lymphoma is extremely rare. Since the adrenal gland has a sufficient reserve, development of adrenal insufficiency requires destruction of more than 90% of the adrenal gland tissue (2) . Wereport a female patient whowas diagnosed as adrenal failure caused by primary bilateral adrenal lymphoma.
Primary lymphomain both adrenal glands is typically con- plasma ACTH620 pg/ml, plasma cortisol 8.9 |ug/dl, and abdominal computed tomography (CT) revealed bilateral adrenal tumors in July. In August 2001, she was admitted to our hospital to determine the relationship between adrenal failure and bilateral adrenal tumors. Physical examination on admission showed body height of 138.6 cm and weight 46.4 kg, blood pressure 120/68 fnmHg, pulse rate of 84 beats/minute and body temperature of 36.6°C. There was no anemia, icterus, or palpable superficial lymph node. Systemic pigmentation was evident on the trunk, limbs, and lips, together with defluxion of hircus and pubes. Physical examination of the abdomenand extremities was unremarkable and neurological examination was negative.
Laboratory tests (Table 1) showed normal complete blood count and no abnormal findings on urinalysis. Biochemical analysis revealed a high LDHlevel (397 IU/Z). Serum electrolyte examination showed no hyponatremia but elevated levels of serum potassium, leading to suspicion of adrenal failure. Elevated levels of serum CRP (1.6 mg/dl), ESR (49 mm/h) and soluble interleukin-2 (IL-2) receptor (1,830.4 U/ml) were also noted. aldosterone were low, i.e., all adrenocortical hormoneswere at low levels. The results of rapid and continuous ACTHtests are shown in Table 3 . Plasma cortisol levels remained low and showed no response in both of the rapid and continuous ACTHtests, revealing primary adrenal failure. Abdominal enhanced CTdetected two masses measuring 5.0 cm and 3.0 cm in the right and left adrenal gland, respectively, with comparable and homogeneous density (Fig. 1A) . No celiac lymph node enlargement was detected on abdominal CT. Magnetic resonance images (MRI) of the left adrenal tumor revealed comparatively normal form on T2-weighted, but the right adrenal tumor was slightly heterogeneous with irregular surface on T2-weighted MRI (Fig. IB) . Therefore, we suspected metastatic adrenal tumors and examined the entire body for the primary lesion. However, we could not detect any primary carcinoma. 67Ga scintigram did not reveal abnormal uptake in the adrenal glands and other organs. Repeated serum electrolyte examinations revealed no exacerbation after admission. Since hypoglycemia was frequently detected while the patient was still on voglibose (0.9 mg/day) and glimepiride (6 mg/day), both medications were withheld. Replacement therapy for primary adrenal failure commenced on August 30, 2001 with 30 mg/day hydrocortisone, which resulted in immediate improvement of nausea, vomiting, and general fatigue, and disappearance of hypoglycemia. However, blood sugar levels gradually increased, ne- cessitating treatment with voglibose (0.9 mg/day) and nateglinide (270 mg/day).
Several imaging studies were subsequently conducted to detect the cause of adrenal tumors. The differential diagnosis at that stage included malignant lymphoma, metastatic adrenal tumors, and adrenal cortical carcinomas. Therefore, she was transferred to The Department of Urology for resection of both adrenal tumors, which was performed on September 25 using the celiotomy approach. Gross examination showed both tumors were 5.0 cm in diameter, and the right tumorwasadherent to the inferior vena cava and liver. However,no diagnosis could be madeunder the operation apart from carcinoma, and therefore bilateral adrenalectomy was performed. Histopathologically, both tumors contained large pleomorphic lymphoid cells with heteromorphous nuclei (Fig. 2A, B) . These cells showed extensive infiltration mainly into the sinusoids and venules within the tumor mass. Immunohistochemical staining demonstrated that the most tumor cells were positive for B cell markers, CD20 and CD79a (Fig. 2C) . Furthermore, although the tumor cells were stained for bcl-2, they did not stain for CD5(data not shown). Based on histopathological assessment, the final diagnosis was intravascular large B-cell lymphoma(IVL), a subtype of extranodal diffuse large B-cell lymphomacharacterized by the presence of lymphomacells in the lumina of small vessels. Following the resection of bilateral adrenal glands, serum electrolytes and blood glucose levels improved under the replacement therapy with hydrocortisone (30 mg/day).
Moreover, the skin pigmentation improved gradually, and plasma ACTHdecreased to 17.6 pg/ml. However, after the operation, persistence of symptomsof general fatigue, appetite loss, low-grade fever, steal sweat and elevation of CRP, LDH, soluble IL-2 receptor, was noted. The activity of NHL 3A) , indicating brain metastases. Moreover, bone metastases were detected on bone MRI (Fig. 3B) . Chemotherapy using EPOCH (etoposide 65 mg, vincristine sulfate 0.5 mg, doxorubicin 13 mg, and prednisolone 80 mg) combined with whole brain and myelic irradiation failed to induce any clinical improvement and the patient died due to high disease activity. Her family refused postmortem examination.
Discussion
Wetreated a 66-year-old womanwho was diagnosed with bilateral primary adrenal malignant lymphoma.The most common manifestations of malignant lymphoma are the involvement of the amygdale, stomach and pharynx, in addition to the lymph nodes, although the involvement of various other organs has been described. Involvement of the adrenal gland in malignant lymphomacases is reported to be 25%at autopsy (3), but malignant lymphoma arising in the endocrine glands represents only 3% of extranodal malignant lymphomas, and is usually confined to the thyroid gland.
Therefore, primary adrenal malignant lymphomais rare (1).
The present patient showed typical symptoms and endocrinological findings of adrenal failure. Moreover, both rapid and continuous ACTHtests revealed no response, thus indicating primary adrenal failure. Primary adrenal malignant lymphomawas described in 24 patients of 67 reported cases complicated with adrenal failure including subclinical or partial adrenal failure (4, 5) . In other words, 36%of cases with primary adrenal malignant lymphomawere complicated with adrenal insufficiency (Table 4) . These reports showed certain characteristic features for primary adrenal malignant lymphoma,such as male predilection, involvement of both adrenal glands and being of the diffuse large B cell type. Thus, malignant lymphomawas suspected in our case based on the high levels of LDHand soluble IL-2 receptor, bilateral adrenal tumors, rapidly progressive adrenal insufficiency. However, 67Ga scintigram, did not demonstrate increased uptake in the adrenal glands, and T2-weighted MRIrevealed heterogeneous tumors in our case. The heterogeneous tumors on imaging studies are usually tumors with bleeding and necrosis, making it very difficult to differentiate malignant lymphoma form adrenal metastatic tumors or adrenal cortical carcinomas (6, 7) . Therefore, the complication of two or more diseases was considered in our case. Accordingly, surgery was performed to allow rapid histopathological examination under operation for the final diagnosis. However, no diagnosis could be made under the operation apart from carcinoma, and therefore bilateral adrenalectomy was performed. The final diagnosis was IVL based on histopathological examination. IVL was classified as diffuse large B-cell lymphomasubtype, according to the new WHO classification (8) . Several cases of IVL have been reported since the first patient was reported by Pfleger and Tappeiner (9) .
Generally, antemortem diagnosis of IVL is very difficult be- eruptions, neurological symptoms, and weight loss (10, 1 1) .
Moreover, the most commonmanifestations of IVLare infiltration of the skin and central nervous system, although infiltration of atypical cells has been described in various organs (12) . Numao et al (13) indicated that primary and secondary adrenal gland infiltration of IVL was detected in 67% of patients diagnosed with IVL. The present case also showed infiltration of the central nervous system and liver and the clinical course progressed rapidly. Five cases of primary adrenal IVL had been reported until now in Japan, and two of these cases showedcentral nervous system infiltration, as described in our case (12) (13) (14) (15) . Therefore, central nervous system infiltration is described in 50%of Japanese patients with primary adrenal IVL including our case, and we consider central nervous system infiltration to be very important for the diagnosis of primary adrenal IVL. Furthermore, in cases with lymphomacell infiltration detected in both glands and atypical imaging examination, and rapidly progressive adrenal insufficiency, the possibility that imaging examination is modified by bleeding caused by embolism of lymphoma cells in blood vessels, should be considered. On the other hand, the sensitivity of IVLto systemic chemotherapy is very high and particularly when early diagnosis is made followed by treatment at an early stage. Therefore, early diagnosis and treatment of IVL is crucial for prognosis. Recent studies showed that de novo CD5+diffuse large Bcell lymphoma (CD5+ DLBCL) is phenotypically and genotypically different from CD5 DLBCL (16) . The survival of patients with CD5+DLBCLis significantly worse than that of patients with CD5" DLBCL. Moreover, several patients with CD5+ IVL have been described (17, 18) .
However, in the present case the tumor cells did not stain for CD5.
In conclusion, we reported a rare and important case of bilateral primary adrenal non-Hodgkin lymphoma presenting as adrenal failure. Our patient was diagnosed as NHLwith IVL. IVL is often very difficult to diagnose despite the multitude of laboratory tests and imaging studies. Thus, IVL should be suspected in patients with bilateral adrenal tumors whopresent with rapidly progressive adrenal failure.
